Halil Şenol
Halil Şenol publishes mostly in Organic Chemistry, Molecular Biology and Pharmacology, on topics such as Synthesis and biological activity, Enzyme function and inhibition and Cholinesterase and Neurodegenerative Diseases.
- World rank
- #67,276 of 7,710,434 ranked researchers
- Rank in Türkiye
- #165 of 117,622
- Works
- 110
- Citations
- 1.8k
- Citations per work
- 16.6
What does Halil Şenol research?
Halil Şenol's work is mostly in Chemistry (36%), Biochemistry, Genetics and Molecular Biology (22%), Medicine (12%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences4439.8%
- Chemistry4036.1%
- Computer Science43.7%
- Everything else2926.8%
- Life Sciences2421.7%
- Health Sciences1311.7%
- Medicine1311.7%
- 1Organic Chemistry36% of their works
- 2Molecular Biology20% of their works
- 3Pharmacology8% of their works
- 4Computational Theory and Mathematics4% of their works
- 5Oncology3% of their works
- 6Cell Biology2% of their works
Research topics
- Synthesis and biological activity
- Enzyme function and inhibition
- Cholinesterase and Neurodegenerative Diseases
- Synthesis and Characterization of Heterocyclic Compounds
- Quinazolinone synthesis and applications
- Computational Drug Discovery Methods
- Natural product bioactivities and synthesis
- Synthesis and Biological Evaluation
Which keywords describe Halil Şenol's research?
The keywords of their largest research topics: Anticancer Agents, Medicinal Chemistry, Heterocyclic Compounds, Tubulin Inhibitors, Vascular Targeting Agents, Drug Discovery, Biological Evaluation and Synthesis.
- Quinoxaline
- Triterpenoids
- Virtual Screening
- Triazines
- Quinazoline
- Anti-inflammatory
- Acetylcholinesterase
- Antimicrobial
- Inhibitors
- Synthesis
- Drug Discovery
- Tubulin Inhibitors
- Medicinal Chemistry
- Anticancer Agents
- Heterocyclic Compounds
- Vascular Targeting Agents
- Biological Evaluation
- Carbonic Anhydrases
- Anticancer
- Molecular Docking
- Cholinesterase Inhibitors
- Indirubin
- Scaffold
- Drug Target Identification
- Saponins
- Antimicrobial Activity
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 26 words, with their numbers
- Anticancer Agents803 topics
- Medicinal Chemistry653 topics
- Heterocyclic Compounds532 topics
- Tubulin Inhibitors451 topic
- Vascular Targeting Agents451 topic
- Drug Discovery402 topics
- Biological Evaluation343 topics
- Synthesis343 topics
- Carbonic Anhydrases271 topic
- Inhibitors271 topic
- Anticancer262 topics
- Antimicrobial262 topics
- Molecular Docking252 topics
- Acetylcholinesterase241 topic
- Cholinesterase Inhibitors241 topic
- Anti-inflammatory222 topics
- Indirubin131 topic
- Quinazoline131 topic
- Scaffold131 topic
- Triazines131 topic
- Drug Target Identification121 topic
- Virtual Screening121 topic
- Saponins91 topic
- Triterpenoids91 topic
- Antimicrobial Activity81 topic
- Quinoxaline81 topic
Where does Halil Şenol work?
Halil Şenol's main affiliation in the publication record is Bezmiâlem Vakıf Üniversitesi, Türkiye.
How many publications and citations does Halil Şenol have?
OpenAlex counts 110 works and 1,827 citations for Halil Şenol, an h-index of 27, ranking #67,276 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Halil Şenol. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.